A Wait-and-see Strategy with Subsequent Self-expanding Metal Stent on Demand is Superior to Prophylactic Bypass Surgery for Unresectable Periampullary Cancer

Overview

Journal HPB (Oxford)

Publisher Elsevier

Specialty Gastroenterology

Date 2016 Jan 19

PMID 26776858

Citations 8

Authors

Caroline Williamsson

Johanna Wennerblom

Bobby Tingstedt

Claes Jonsson

Affiliations

Soon will be listed here.

Abstract

Background: A patient with unresectable periampullary malignancy found at laparotomy has traditionally received a prophylactic double bypass (biliary and duodenal), associated with considerable morbidity. With modern endoscopic treatments, surgical bypass has become questionable. This study aims to compare the two strategies. Sahlgrenska University Hospital (SU) performs a double bypass (DoB) routinely, and Skåne University Hospital Lund (SUL) secures biliary drainage endoscopically and treats only symptomatic duodenal obstruction (Wait and See, WaS).

Method: Between 2004 and 2013, 73 patients from SU and 70 from SUL were retrospectively identified. Demographics, tumour-related factors and postoperative outcomes during the remaining lifetime were noted.

Results: The DoB group had significantly more complications (67% vs. 31%, p = 0.00002) and longer hospital stay (14 vs. 8 days, p = 0.001) than the WaS-group. The two groups had similar proportion of patients in need of readmission. The DoB patients and the WaS patients with metallic biliary stents were comparable regarding their need of re-interventions and hospitalisation due to biliary obstruction. Surgical duodenal bypass did not prevent future duodenal obstructions.

Conclusion: Patients with unresectable periampullary malignancies can safely be managed with endoscopic drainage on demand and with lower morbidity and shorter hospital stay than with surgical prophylactic bypass.

Citing Articles

Palliative management for malignant biliary obstruction and gastric outlet obstruction from pancreatic cancer.

Wu P, Chen K, He J Ann Gastroenterol Surg. 2025; 9(2):218-225.

PMID: 40046529 PMC: 11877337. DOI: 10.1002/ags3.12902.

[Patient safety in palliative surgery].

Hofmann F, Sirtl S, Heiliger C, Werner J Chirurgie (Heidelb). 2025; 96(3):179-183.

PMID: 39808186 DOI: 10.1007/s00104-024-02202-x.

Practice guidelines for managing extrahepatic biliary tract cancers.

Kim H, Kang M, Kang J, Kim K, Kim B, Kim S Ann Hepatobiliary Pancreat Surg. 2024; 28(2):161-202.

PMID: 38679456 PMC: 11128785. DOI: 10.14701/ahbps.23-170.

Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry.

Hofmann F, Miksch R, Weniger M, Keck T, Anthuber M, Witzigmann H BMC Surg. 2022; 22(1):389.

PMID: 36368993 PMC: 9652845. DOI: 10.1186/s12893-022-01833-3.

Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches.

Lee S, Han S, Kang C, Kwon W, Paik K, Song K Ann Hepatobiliary Pancreat Surg. 2022; 26(1):1-16.

PMID: 35220285 PMC: 8901981. DOI: 10.14701/ahbps.22-009.

References

Fiori E, Lamazza A, Volpino P, Burza A, Paparelli C, Cavallaro G . Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004; 24(1):269-71. View

Dindo D, Demartines N, Clavien P . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-13. PMC: 1360123. DOI: 10.1097/01.sla.0000133083.54934.ae. View

Johnsson E, Thune A, Liedman B . Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg. 2004; 28(8):812-7. DOI: 10.1007/s00268-004-7329-0. View

Michelassi F, Erroi F, Dawson P, Pietrabissa A, Noda S, Handcock M . Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg. 1989; 210(4):544-54; discussion 554-6. PMC: 1357942. DOI: 10.1097/00000658-198910000-00015. View

Singh S, LONGMIRE Jr W, Reber H . Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg. 1990; 212(2):132-9. PMC: 1358046. DOI: 10.1097/00000658-199008000-00003. View

de Rooij P, Rogatko A, Brennan M . Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg. 1991; 78(9):1053-8. DOI: 10.1002/bjs.1800780909. View

Watanapa P, Williamson R . Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg. 1992; 79(1):8-20. DOI: 10.1002/bjs.1800790105. View

Davids P, Groen A, Rauws E, Tytgat G, Huibregtse K . Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992; 340(8834-8835):1488-92. DOI: 10.1016/0140-6736(92)92752-2. View

Espat N, Brennan M, Conlon K . Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg. 1999; 188(6):649-55; discussion 655-7. DOI: 10.1016/s1072-7515(99)00050-2. View

10.

Lillemoe K, Cameron J, Hardacre J, Sohn T, Sauter P, Coleman J . Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg. 1999; 230(3):322-8; discussion 328-30. PMC: 1420877. DOI: 10.1097/00000658-199909000-00005. View

11.

Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A . Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging. 2005; 30(4):488-500. DOI: 10.1007/s00261-004-0279-z. View

12.

Moss A, Morris E, Mac Mathuna P . Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 2006; (1):CD004200. DOI: 10.1002/14651858.CD004200.pub2. View

13.

Maire F, Hammel P, Ponsot P, Aubert A, OToole D, Hentic O . Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol. 2006; 101(4):735-42. DOI: 10.1111/j.1572-0241.2006.00559.x. View

14.

Artifon E, Sakai P, Cunha J, DuPont A, Filho F, Hondo F . Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol. 2006; 101(9):2031-7. DOI: 10.1111/j.1572-0241.2006.00764.x. View

15.

Koninger J, Wente M, Muller M, Gutt C, Friess H, Buchler M . Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg. 2006; 392(1):13-21. DOI: 10.1007/s00423-006-0100-2. View

16.

Shaib Y, Davila J, Naumann C, El-Serag H . The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol. 2007; 102(7):1377-82. DOI: 10.1111/j.1572-0241.2007.01202.x. View

17.

Jeurnink S, van Eijck C, Steyerberg E, Kuipers E, Siersema P . Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol. 2007; 7:18. PMC: 1904222. DOI: 10.1186/1471-230X-7-18. View

18.

Wente M, Bassi C, Dervenis C, Fingerhut A, Gouma D, Izbicki J . Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007; 142(5):761-8. DOI: 10.1016/j.surg.2007.05.005. View

19.

Weber A, Mittermeyer T, Wagenpfeil S, Schmid R, Prinz C . Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer. Pancreas. 2008; 38(1):e7-e12. DOI: 10.1097/MPA.0b013e3181870ab8. View

20.

Mayo S, Austin D, Sheppard B, Mori M, Shipley D, Billingsley K . Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?. J Am Coll Surg. 2009; 208(1):87-95. DOI: 10.1016/j.jamcollsurg.2008.10.014. View